DarioHealth Corp. (DRIO): who owns it and who trades it
As of Nov 16, 2026, DRIO insiders reported 1 purchase worth $100K in the last 12 months. The largest buyer was Dennis Matheis (Director), with $100K. 1 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling DarioHealth
From the latest filingsOverall: more buying than selling. Insiders and famous investors mostly bought.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Insider trades
In the last 12 months, DRIO insiders reported $100K of open-market purchases and $0 of sales.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jul 23, 2026 | Dennis Matheis | Director | Purchase | 14,430 | $6.93 | $100K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Dennis Matheis | Director | $100K | – | Jul 23, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
DRIO short interest
Low short interest. 1.2% of DRIO shares are sold short: about 1 share in 85. Over the last 12 reports the number of shares short went up 57%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 114,624 DRIO shares were sold short, 1.2% of the shares outstanding, up 41.1% from the report before. At the average daily volume of 95,080 shares, buying them all back would take about 1.2 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 114,624 | 1.17% | +41% | 95,080 | 1.2 |
| Oct 15, 2026 | 81,229 | 0.83% | -0% | 18,591 | 4.4 |
| Sep 30, 2026 | 81,615 | 0.83% | +4% | 18,516 | 4.4 |
| Sep 15, 2026 | 78,186 | 0.80% | +4% | 28,993 | 2.7 |
| Aug 31, 2026 | 75,075 | 0.77% | -9% | 26,112 | 2.9 |
| Aug 14, 2026 | 82,831 | 0.85% | -3% | 32,789 | 2.5 |
| Jul 31, 2026 | 85,772 | 1.17% | +13% | 23,137 | 3.7 |
| Jul 15, 2026 | 75,831 | 1.04% | -1% | 15,951 | 4.8 |
| Jun 30, 2026 | 76,972 | 1.05% | -3% | 13,521 | 5.7 |
| Jun 15, 2026 | 79,728 | 1.09% | +13% | 7,363 | 10.8 |
| May 29, 2026 | 70,660 | 0.97% | -3% | 6,532 | 10.8 |
| May 15, 2026 | 72,783 | 1.00% | +9% | 6,892 | 10.6 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
DarioHealth company events
DarioHealth filed 9 reports on Form 8-K in the last 12 months, 5 of them about an important change (leadership). The latest was on Nov 6, 2026.
- Nov 6, 2026LeadershipOn the recommendation of the Nominating Committee of the Board of Directors, or the Board, of DarioHealth Corp., or the Company, the Board appointed John R. Palumbo as Chairman of the Board, effective immediately, succeeding Yoav Shaked, who will continue to serve as a member of the Board. Filing
- Sep 4, 2026LeadershipLawrence Leisure notified the Board of Directors of DarioHealth Corp. of his decision to retire from the Board, effective September 2, 2026, for personal reasons. Filing
- Aug 21, 2026LeadershipAs previously disclosed, on July 10, 2026, the temporary medical leave of absence of Steven Nelson, President and Chief Commercial Officer of DarioHealth Corp., was extended for an indefinite period. Filing
- Jul 22, 2026AgreementDarioHealth Corp. entered into a Securities Purchase Agreement with institutional investors, pursuant to which the Company agreed to issue and sell to the investors in a registered direct offering priced at-the-market under Nasdaq rules an aggregate of 2,437,060 shares of the Company’s common… Filing
- Jul 10, 2026LeadershipThe temporary medical leave of absence of Steven Nelson, President and Chief Commercial Officer of DarioHealth Corp., or the Company, was extended for an indefinite period. Filing
- Apr 13, 2026LeadershipOn the recommendation of the Nominating and Corporate Governance Committee of the Board of Directors, or the Board, of DarioHealth Corp., or the Company, the Board appointed John R. Palumbo as a member of the Board, effective immediately. Filing
- Mar 30, 2026AgreementDarioHealth Corp., a Delaware corporation, entered into a sales agreement with A.G.P./Alliance Global Partners, pursuant to which the Company may issue and sell, from time to time, up to an aggregate of $20 million of shares of its common stock, par value $0.0001 per share, through an “at the… Filing
- Feb 2, 2026RulesChanged its bylaws or articles. Filing
- Jan 29, 2026VoteReported shareholder vote results. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
DarioHealth financials
Famous investors that hold DRIO
1 of the 50 well-known investors we track reported holding DRIO in their latest 13F filing. The largest position is Ken Griffin's, worth $3M.
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Ken Griffin · Citadel Advisors | Q3 2026 | 447,619 | $3M | 0.0% | +1743% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named DRIO in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Nov 13, 2026 | Nantahala Capital Management, LLC | 13G/A | 10.0% |
| Nov 13, 2026 | Nantahala Capital Management, LLC | 13G/A | 10.0% |
Questions about DarioHealth Corp. (DRIO) stock
Are DRIO insiders buying or selling?
In the last 12 months, DRIO insiders reported 1 open-market purchase worth $100K and no sales. The latest trade was on Jul 23, 2026. See every trade.
What is the short interest in DRIO?
As of Oct 30, 2026, 114,624 DRIO shares were sold short, 1.2% of the shares outstanding, up 41.1% from the report before. At the average daily volume of 95,080 shares, buying them all back would take about 1.2 trading days (days to cover). See the history.
Which famous investors hold DRIO?
1 of the 50 well-known investors we track reported DRIO in their latest 13F filing, including Ken Griffin. The largest position is worth $3M. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.